Dongfang Liu's most recent trade in Nuvation Bio Inc - Ordinary Shares - Class A was a trade of 20,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 2, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Nuvation Bio Inc Ordinary | Dongfang Liu | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2025 | 20,000 | 480,000 | - | - | Stock Option (Right to Buy) | |
Nuvation Bio Inc Ordinary | Dongfang Liu | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 2.50 per share. | 02 May 2025 | 20,000 | 12,000 | - | 2.5 | 50,024 | Class A Common Stock |
Nuvation Bio Inc Ordinary | Dongfang Liu | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.94 per share. | 02 May 2025 | 20,000 | 32,000 | - | 1.9 | 38,800 | Class A Common Stock |
Nuvation Bio Inc Ordinary | Dongfang Liu | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
Nuvation Bio Inc Ordinary | Dongfang Liu | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
Nuvation Bio Inc Ordinary | Dongfang Liu | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
Nuvation Bio Inc Ordinary | Dongfang Liu | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2022 | 315,000 | 315,000 | - | - | Stock Option (Right to Buy) | |
Nuvation Bio Inc Ordinary | Dongfang Liu | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 490,000 | 490,000 | - | - | Stock Option (Right to Buy) | |
Nuvation Bio Inc Ordinary | Dongfang Liu | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 292,500 | 292,500 | - | - | Stock Option (Right to Buy) |